American Association for Cancer Research

sorry, we can't preview this file

crc-22-0037-s06.xlsx (928.47 kB)

Supplementary File 2 from Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer

Download (928.47 kB)
posted on 2023-04-04, 01:22 authored by Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeff P. Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X. Chen, Sarbjot Gill, Neesha C. Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G. Wouters, Amit M. Oza, Anthony M. Joshua, Stephanie Lheureux

CRISPR screen TOV1946. Results of the Itra sensitizing CRISPR screen on the TOV1946 cell line using drugZ algorithm.


Government of Ontario (Ontario Government)



The combination of the antifungal drug itraconazole with antimalarial drug hydroxychloroquine leads to a cytotoxic lysosomal dysfunction, supporting the rational for further research on lysosomal targeting in ovarian cancer.